论文部分内容阅读
静脉注射免疫球蛋白（Ｉｎｔｒａｖｅｎｏｕｓ ｉｍ－ｍｕｎｏｇｌｏｂｕｌｉｎ，ＩＶＩＧ）自２０世纪７０年代末开始用于临床，随着对其作用机理认识的逐渐深入，其临床适应证不断扩大，应用日趋广泛，现将其在儿科各系统疾病中的应用情况介绍如下。 临床应用的主要适应证及
Intravenous im-munoglobulin (IVIG) has been used clinically since the late 1970s. With the deepening of understanding of its mechanism of action, its clinical indications have been expanded and used more and more widely. Pediatric system diseases in the application are described below. The main indications of clinical application and